Dr. Chua Hshan Cher was appointed Deputy Chief Executive Officer of the Company on 1 March 2022 and is responsible for providing strategic and operational leadership to the Livingstone Health team. He works closely with CEO Dr. Wilson Tay to develop management practices that support a high-performing and effective executive team.
A veteran clinician with 20 years of experience in family medicine, Dr. Chua graduated from the National University of Singapore with a Bachelor of Medicine and Bachelor of Surgery in 2003 followed by a Diploma in Dermatology from Cardiff University in 2012.
Dr. Chua founded Phoenix Medical Group (“PMG”) in 2012 and steadily expanded it into a network of eight clinics across Singapore by 2025. He led the seamless integration of PMG into Livingstone Health, enhancing the Group’s primary care capabilities and extending its national reach. Under his leadership, PMG also identified the first COVID-19 case in Singapore, and he played a pivotal role in introducing the Sinovac vaccine, bolstering the national pandemic response.
